Behavioural characterisation of the effects of acute and repeated administration of GBR 12909 in rats: further evaluation of a potential model of ADHD. by Hewitt, K, Marsden, C, Hollis, C, Fone, K

Digital technology: coming of age? by Marzano, L, Hollis, C, Cipriani, A, Malhi, G

Looking before you leap: a theory of motivated control of action. by Liddle, E, Scerif, G, Hollis, C, Batty, M, Groom, M, Liotti, M, Liddle, P

Autistic spectrum disorder traits in children with attention deficit hyperactivity disorder. by Kochhar, P, Batty, M, Liddle, E, Groom, M, Scerif, G, Liddle, P, Hollis, C

Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder. by Hewitt, K, Shah, Y, Prior, M, Morris, P, Hollis, C, Fone, K, Marsden, C

Motivational incentives and methylphenidate enhance electrophysiological correlates of error monitoring in children with attention deficit/hyperactivity disorder by Groom, M, Liddle, E, Scerif, G, Liddle, P, Batty, M, Liotti, M, Hollis, C

Motivational incentives and methylphenidate enhance electrophysiological correlates of error monitoring in children with attention deficit/hyperactivity disorder. by Groom, M, Liddle, E, Scerif, G, Liddle, P, Batty, M, Liotti, M, Hollis, C

Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply by Cipriani, A, Adamo, N, Giovane, C, Coghill, D, Banaschewski, T, Hollis, C, Zuddas, A, Simonoff, E, Cortese, S

Trends in antidepressant prescriptions in children and young people in England, 1998-2017: protocol of a cohort study using linked primary care and secondary care datasets by Jack, RH, Hollis, C, Coupland, C, Morriss, R, Knaggs, RD, Cipriani, A, Cortese, S, Hippisley-Cox, J

Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. by Liddle, E, Hollis, C, Batty, M, Groom, M, Totman, J, Liotti, M, Scerif, G, Liddle, P

Effects of motivation and medication on electrophysiological markers of response inhibition in children with attention-deficit/hyperactivity disorder. by Groom, M, Scerif, G, Liddle, P, Batty, M, Liddle, E, Roberts, K, Cahill, J, Liotti, M, Hollis, C

Evaluating digital health interventions: key questions and approaches by Murray, E, Hekler, E, Andersson, G, Collins, L, Doherty, A, Hollis, C, Rivera, D, West, R, Wyatt, J

Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study by Jack, RH, Hollis, C, Coupland, C, Morriss, R, Knaggs, RD, Butler, D, Cipriani, A, Cortese, S, Hippisley-Cox, J

Cortical gray matter in attention-deficit/hyperactivity disorder: a structural magnetic resonance imaging study. by Batty, M, Liddle, E, Pitiot, A, Toro, R, Groom, M, Scerif, G, Liotti, M, Liddle, P, Paus, T, Hollis, C

Secondary care specialist visits made by children and young people prescribed antidepressants in primary care: a descriptive study using the QResearch database by Jack, RH, Joseph, RM, Coupland, C, Butler, D, Hollis, C, Morriss, R, Knaggs, RD, Cipriani, A, Cortese, S, Hippisley-Cox, J

Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised con... by Morrison, AP, Pyle, M, Maughan, D, Johns, L, Freeman, D, Broome, MR, Husain, N, Fowler, D, Hudson, J, MacLennan, G, Norrie, J, Shiers, D, Hollis, C, James, A, MAPS group

Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysi... by Cortese, S, Adamo, N, Del Giovane, C, Mohr-Jensen, C, Hayes, A, Carucci, S, Atkinson, L, Tessari, L, Banaschewski, T, Coghill, D, Hollis, C, Simonoff, E, Zuddas, A, Barbui, C, Purgato, M, Steinhausen, H, Shokraneh, F, Xia, J, Cipriani, A

Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT by Morrison, AP, Pyle, M, Byrne, R, Broome, M, Freeman, D, Johns, L, James, A, Husain, N, Whale, R, MacLennan, G, Norrie, J, Hudson, J, Peters, S, Davies, L, Bowe, S, Smith, J, Shiers, D, Joyce, E, Jones, W, Hollis, C, Maughan, D

Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing adolescent first episode Psychosis: a feasibility study (MAPS) by Pyle, M, Broome, M, Joyce, E, Maclennan, G, Norrie, J, Freeman, D, Fowler, D, Haddad, P, Shiers, D, Hollis, C, Smith, J, Liew, A, Byrne, R, French, P, Peters, S, Hudson, J, Davies, L, Emsley, R, Yung, A, Birchwood, M, Longden, E, Morrison, A

Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange) by Freeman, D, Yu, L-M, Kabir, T, Martin, J, Craven, M, Leal, J, Lambe, S, Brown, S, Morrison, A, Chapman, K, Dudley, R, O'Regan, E, Rovira, A, Goodsell, A, Rosebrock, L, Bergin, A, Cryer, TL, Robotham, D, Andleeb, H, Geddes, JR, Hollis, C, Clark, DM, Waite, F